<DOC>
	<DOCNO>NCT01631032</DOCNO>
	<brief_summary>Allergic rhinitis common complicate immunologic disorder disease multiple western medicine use symptom control . Chinese herbal medicine , one commonly use complementary alternative medicine Taiwan , also use allergic rhinitis control . This study design explore efficacy possible underlying immune-modulation effect BZYQT , one famous Chinese herbal medicine use allergic rhinitis daily practice .</brief_summary>
	<brief_title>Effect Qi-tonifying Chinese Herbal Products Treatment Allergic Rhinitis</brief_title>
	<detailed_description>Allergic rhinitis type I hypersensitivity reaction nasal mucosa environmental allergen . It characterize one symptom include sneezing , itching , rhinorrhea nasal congestion . The prevalence allergic rhinitis Taiwan approximately 20 % -30 % increase annually . However , symptom relapse still bother majority patient though certain advance western medicine . In addition , side effect western medicine , lethargy , mouth dryness take anti-histamine immunosuppression use steroid also concerned patient . Traditional Chinese medicine use widely Taiwan several disease , especially allergic disease , allergic rhinitis . Among Chinese herbal product , qi-tonifying regimen play central role allergic disease control . Bu-zhong-yi-qi-tang ( BZYQT ) , one famous qi-tonifying herbal product , prove immuno-modulation effect previous study . However , proof clinical investigation therapeutic efficacy cellular level response still lack . In study , double-blinded , randomize , placebo control design apply total 120 intermittent allergic rhinitis patient enrol study . All subject divide BZYQT placebo control group , group 60 subject . Subjects BZYQT group receive capsule BZYQT , 3gm tid , 9gm day , control group receive similar placebo capsule scheme . Total 2 month treatment course do . Clinical evaluation , include symptom severity , quality life chronic fatigue degree do per month one month complete treatment . Additionally , various parameter immunologic response check treatment , include total IgE amount , ratio CD4/CD8 T lymphocytes , profile cytokine IL-4 , IL-5 , IL-8 , IL-10 , IL-13 , IFN-Î³ well PGE2 , LTC4 , sICAM-1 , mRNA expression COX2 neutrophil phagocytosis . Dendritic cell function , presumably important immune-response inducer , also check test IL-10 IL-12 . Results analyze statistically include gender analysis . We hope therapeutic efficacy possible cellular mechanism immune-modulation elucidate complete clinical trial .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Patients one follow symptom : nose itching , sneeze , rhinorrhea clear nasal discharge , stuffy nose . exacerbation time less 4 day week consecutive episode less four week Mite allergy confirm Childhood Allergy Panel ( CAP ) Use steroid , antihistamine , Montelukast immunomodulation drug duration drug discontinuation le one month Active infection , include sinusitis Vasomotor rhinitis Unable swallow capsule history poor medication compliance Major organ dysfunction relevant impair physical performance status</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Allergic rhinitis</keyword>
	<keyword>Chinese herbal product</keyword>
	<keyword>Qi deficiency</keyword>
</DOC>